Bonumtherapeutics
Bonumtherapeutics, operating as Bonum Tx, develops antibody‑controlled therapeutics that deliver potent activity only where needed, aiming to improve safety and efficacy across oncology, autoimmunity, metabolic disorders, and pain management. The company leverages a novel regulated protein platform validated by Roche’s acquisition of its predecessor Good Therapeutics in 2022, and is advancing preclinical programs targeting immune cells and tumor microenvironments.
Bonumtherapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Antibody, and Oncology.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Bonum Tx API
API for Bonum Tx platform providing access to therapeutic data and program information.
Privacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Bonumtherapeutics API — frequently asked questions
Does Bonumtherapeutics have an API?
Yes. APIs.io lists 1 API from Bonumtherapeutics, including Bonum Tx API.
Is the Bonumtherapeutics API ready for AI agents?
Bonumtherapeutics has a Kin Score of 6.4 out of 100 (minimal) and an Agent Readiness score of 0.0 (human-only), scored by API Evangelist on 2026-11-13.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.